Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirusJacob A. Dillard, Mark T. Heise|Nature Communications|2024Cited by 15
Adjuvant-dependent effects on the safety and efficacy of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirusMark T. Heise, Victoria K. Baxter|Research Square|2023Cited by 0